As the major cost-cutting initiative at Bristol Myers Squibb rolls on, the company has launched another round of layoffs in ...

The move comes less than a year after the company attempted to save $1.5 billion through the layoff of some 2,200 employees.

Just nine months after announcing a massive plan to cut costs, Bristol Myers Squibb has gone one better, revealing a new goal to save even more money.

Bristol Myers Squibb will make even deeper cuts to its organization to enhance efficiencies as it faces the 2028 loss of ...

Last year, Bristol Myers Squibb devoted half a page of its annual report to its diversity, equity and inclusion efforts, ...

Bristol-Myers Squibb (SMY) stock falls as its Q4 2024 results beat Street forecasts, but its 2025 outlook fell short of ...

On a per-share basis, the Princeton, New Jersey-based company said it had net income of 4 cents. Earnings, adjusted for non-recurring costs, came to $1.67 per share. The results surpassed Wall Street ...

Bristol Myers Squibb will cut $2 billion in costs by the ... allowing the company to invest in new drugs and research. The company previously outlined plans to cut $1.5 billion by 2025, which ...

Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations.

Bristol Myers Squibb's Breyanzi showed strong efficacy in Phase 2 lymphoma trial, meeting key endpoints. FDA approvals expand ...

Bristol Myers Squibb on Thursday posted better-than-expected fourth quarter earnings, but said its 2025 revenue would fall ...